Annual Outcomes With Transcatheter Valve Therapy: From the STS/ACC TVT Registry.
暂无分享,去创建一个
J. Carroll | M. Mack | J. Rumsfeld | E. Tuzcu | F. Grover | E. Peterson | R. Brindis | D. Holmes | R. Nishimura | F. Edwards | D. Shahian | V. Thourani | S. Fitzgerald | S. Vemulapalli | K. Hewitt | J. Michaels
[1] John D. Carroll,et al. Clinical outcomes at 1 year following transcatheter aortic valve replacement. , 2015, JAMA.
[2] M. Mack,et al. Insights from the early experience of the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry. , 2015, JACC. Cardiovascular interventions.
[3] Tamara Syrek Jensen,et al. Transcatheter valve therapy registry is a model for medical device innovation and surveillance. , 2015, Health affairs.
[4] Sean M. O'Brien,et al. The association of transcatheter aortic valve replacement availability and hospital aortic valve replacement volume and mortality in the United States. , 2014, The Annals of thoracic surgery.
[5] Thoralf M Sundt,et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. , 2014, Journal of the American College of Cardiology.
[6] Thoralf M Sundt,et al. 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. , 2014, Circulation.
[7] P. Serruys,et al. Transcatheter aortic valve replacement and vascular complications definitions. , 2014, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[8] J. Leipsic,et al. Impact of low-profile sheaths on vascular complications during transfemoral transcatheter aortic valve replacement. , 2013, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[9] Sean M. O'Brien,et al. Outcomes following transcatheter aortic valve replacement in the United States. , 2013, JAMA.
[10] L. Jordaens,et al. Pacemaker dependency after transcatheter aortic valve implantation with the self-expanding Medtronic CoreValve System. , 2013, International journal of cardiology.
[11] Danica Marinac-Dabic,et al. The STS-ACC transcatheter valve therapy national registry: a new partnership and infrastructure for the introduction and surveillance of medical devices and therapies. , 2013, Journal of the American College of Cardiology.
[12] Danica Marinac-Dabic,et al. The international registry infrastructure for cardiovascular device evaluation and surveillance. , 2013, JAMA.
[13] J. Spertus,et al. Use of the Kansas City Cardiomyopathy Questionnaire for Monitoring Health Status in Patients With Aortic Stenosis , 2013, Circulation. Heart failure.
[14] M. Mack,et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. , 2012, Journal of the American College of Cardiology.
[15] J. Fajadet,et al. Update on the need for a permanent pacemaker after transcatheter aortic valve implantation using the CoreValve® Accutrak™ system. , 2012, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[16] M. Mack,et al. Rational dispersion for the introduction of transcatheter valve therapy. , 2011, JAMA.
[17] Pascal Vranckx,et al. Standardized endpoint definitions for Transcatheter Aortic Valve Implantation clinical trials: a consensus report from the Valve Academic Research Consortium. , 2011, Journal of the American College of Cardiology.
[18] G. Latsios,et al. VALVULAR AND STRUCTURAL HEART DISEASES Original Studies ‘‘Device Landing Zone’’ Calcification, Assessed by MSCT, as a Predictive Factor for Pacemaker Implantation After TAVI , 2010 .
[19] Gernot Brockmann,et al. Predictors for new-onset complete heart block after transcatheter aortic valve implantation. , 2010, JACC. Cardiovascular interventions.
[20] M. Mack,et al. Reliability of risk algorithms in predicting early and late operative outcomes in high-risk patients undergoing aortic valve replacement. , 2008, The Journal of thoracic and cardiovascular surgery.
[21] J. Spertus,et al. Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: a new health status measure for heart failure. , 2000, Journal of the American College of Cardiology.